Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Net Income (2019 - 2026)

Pliant Therapeutics has reported Net Income over the past 8 years, most recently at -$20.0 million for Q1 2026.

  • Quarterly Net Income rose 64.32% to -$20.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$111.4 million through Mar 2026, up 49.26% year-over-year, with the annual reading at -$147.5 million for FY2025, 29.86% up from the prior year.
  • Net Income was -$20.0 million for Q1 2026 at Pliant Therapeutics, up from -$21.7 million in the prior quarter.
  • Over five years, Net Income peaked at -$20.0 million in Q1 2026 and troughed at -$57.8 million in Q3 2024.
  • The 5-year median for Net Income is -$41.1 million (2023), against an average of -$39.0 million.
  • Year-over-year, Net Income crashed 42.92% in 2022 and then surged 64.32% in 2026.
  • A 5-year view of Net Income shows it stood at -$35.1 million in 2022, then fell by 17.25% to -$41.1 million in 2023, then decreased by 20.98% to -$49.7 million in 2024, then skyrocketed by 56.27% to -$21.7 million in 2025, then grew by 7.86% to -$20.0 million in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Net Income are -$20.0 million (Q1 2026), -$21.7 million (Q4 2025), and -$26.3 million (Q3 2025).